This is an aggregated industry headline. Read the full story at PharmaVoice →
'The window's open': At BIO, investors take stock of a growing class of biotech IPOs
In interviews as well as a panel at BIO's annual meeting, investors and life sciences bankers predicted an acceleration in offerings later this year - but only among companies fitting a certain criteria.
By PharmaVoice
· Jun 23, 2026
· via PharmaVoice
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlinePharmaVoice
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Nominate up-and-coming early-career pharma marketing pros here to be featured in Fierce's "Rising Stars" Q&…
The WeekFierceBiotech ↗
AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese bi…
The WeekBriefing
The FDA posted an updated list of all approved ANDAs with Competitive Generic Therapy designation, including e…